Recent Quotes (30 days)

You have no recent quotes
chg | %

PLX Technology Inc news

  
Showing stories 1 - 10 of about 71   

Articles published

PLXT 0.0000
price chart
Potomac Capital Partners Sends Open Letter To Stockholders Of PLX Technology, Inc.
NEW YORK, Oct. 25, 2013 /PRNewswire/ -- Potomac Capital Partners II, L.P., who beneficially owns, together with its affiliates, approximately 9.8% of the outstanding common stock of PLX Technology, Inc. ("PLX" or the "Company"), today announced that it ...
Related articles »  
Avago Technologies to Acquire PLX Technology
Avago Technologies Ltd. AVGO 0.57% said Monday it will acquire PLX Technology Inc. in an all-cash deal that values PLX at about $298.3 million, as the chip maker looks to expand its enterprise storage and networking offerings.
Avago Tech (AVGO) to Acquire PLX Technology (PLXT) in $309M Deal  StreetInsider.com
Why PLX Technology (PLXT) Stock Is Up Today (Update)  TheStreet.com
Related articles »  
Avago Technologies Limited Successfully Completes Tender Offer for Shares of ...
SINGAPORE, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Avago Technologies Limited ("Avago") (Nasdaq:AVGO), a leading semiconductor device supplier to the enterprise storage, wired, wireless and industrial end markets, announced today that it has ...
Related articles »  
Broadcom Nearing Deal to Settle Lawsuit Over 2014 PLX Technology Takeover
Broadcom Ltd. AVGO -0.80% is nearing a deal to settle a shareholder lawsuit accusing it of underpaying in a 2014 takeover of PLX Technology Inc., according to people familiar with the matter, a case that also leveled allegations of conflicts of ...
China Information Technology, Inc. (NASDAQ:CNIT) and Protalix BioTherapeutics ...
Shares of China Information Technology, Inc. (NASDAQ:CNIT) are experiencing unusual volume during today's trading.
Investor's Roundup (Intraday Analysis): Protalix BioTherapeutics Inc ...  Alpha Beta Stock
Protalix BioTherapeutics Enters into an Exclusive Ex-US Partnership with ...  GlobeNewswire (press release)
FDA Grants Pluristem Orphan Drug Designation for Its PLX-R18 Cell Therapy as ...
HAIFA, Israel, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that the U.S.
Hot Stock's Trend Recap: Protalix BioTherapeutics, Inc. (NYSE: PLX)
Wall Street fell sharply on Thursday, pulling back from record highs, amid a broad decline that was led by technology stocks and disappointing quarterly reports from major companies.
New Published Data Highlights the Potential of Pluristem's PLX Cells in ...
HAIFA, Israel, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (NASDAQ:PSTI) (TASE:PSTI) today announced the publication of results from a preclinical study in the peer-reviewed journal STEM CELLS Translational Medicine.
$7.9 Million Granted to nTRACK Collaborative Project Designed to Study ...
HAIFA, Israel, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that a $7.9 million (€6.8 million) non-dilutive grant from the ... “We ...
Lookout for Price Target? Protalix BioTherapeutics, Inc. (NYSE:PLX), Infinity ...
On Wednesday, Protalix BioTherapeutics, Inc. (NYSE:PLX) reached at $0.83 price level during last trade its distance from 20 days simple moving average is 38.58%, and its distance from 50 days simple moving average is 43.09% while it has a distance of 2 ...